Structures by: Ramesha A. R.
Total: 22
C15H15NOS
C15H15NOS
Crystals (2012) 2, 3 1058-1066
a=9.2080(4)Å b=14.0485(7)Å c=10.3826(6)Å
α=90.00° β=90.00° γ=90.00°
C13H12ClNOS
C13H12ClNOS
Crystals (2012) 2, 3 1058-1066
a=10.3738(7)Å b=10.8501(7)Å c=11.8301(9)Å
α=90.00° β=98.615(7)° γ=90.00°
C13H12ClNOS
C13H12ClNOS
Crystals (2012) 2, 3 1058-1066
a=10.6092(8)Å b=10.8355(8)Å c=11.1346(9)Å
α=90.00° β=98.643(6)° γ=90.00°
C15H13ClN2OS
C15H13ClN2OS
Crystals (2012) 2, 3 1347-1356
a=15.6941(6)Å b=10.7909(4)Å c=8.6586(3)Å
α=90.00° β=102.184(4)° γ=90.00°
C15H13ClN2OS
C15H13ClN2OS
Crystals (2012) 2, 3 1347-1356
a=15.5187(8)Å b=10.9358(5)Å c=8.8141(4)Å
α=90.00° β=101.245(5)° γ=90.00°
C15H13ClN2OS
C15H13ClN2OS
Crystals (2012) 2, 3 1347-1356
a=15.1766(19)Å b=11.2809(14)Å c=8.9334(14)Å
α=90.00° β=98.726(13)° γ=90.00°
4-(4-Carboxybenzyl)-1-methylpiperazin-1-ium picrate
C13H19N2O2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 3 o518
a=7.3020(12)Å b=9.5993(16)Å c=15.131(3)Å
α=86.448(2)° β=79.145(2)° γ=79.950(2)°
5-{5-Chloro-3-[4-(methylsulfonyl)phenyl]-2-pyridyl}-2-methylpyridinium 2,4,6-trinitrophenolate
C18H16ClN2O2S,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 1 o107-o108
a=9.02500(10)Å b=12.74960(10)Å c=21.8011(3)Å
α=90.00° β=98.1140(10)° γ=90.00°
2-Amino-5-nitrophenyl 2-chlorophenyl ketone
C13H9ClN2O3
Acta Crystallographica Section E (2009) 65, 8 o1908-o1909
a=10.6120(3)Å b=11.3314(3)Å c=10.8456(3)Å
α=90.00° β=108.399(3)° γ=90.00°
Desipramine hydrochloride
C18H23N2,Cl
Acta Crystallographica Section E (2010) 66, 3 o674-o675
a=10.7258(3)Å b=15.9997(6)Å c=20.6088(8)Å
α=107.347(3)° β=89.960(2)° γ=99.414(2)°
1-(2-methyl-5-nitrophenyl)guanidinium picrate
C8H11N4O2,C6H2N3O7
Acta Crystallographica Section E (2009) 65, 11 o2788-o2789
a=7.1318(10)Å b=10.6239(13)Å c=11.9564(13)Å
α=84.257(10)° β=74.497(11)° γ=77.559(11)°
11-[3-(Dimethylamino)propyl]-6,11-dihydrodibenzo[<i>b</i>,<i>e</i>]thiepin- 11-ol
C19H23NOS
Acta Crystallographica Section E (2010) 66, 1 o161-o162
a=7.7215(4)Å b=15.3729(10)Å c=27.9274(16)Å
α=90.00° β=95.401(6)° γ=90.00°
1-[2-(2-Bromophenyl)ethyl]-4-chloro-2-nitrobenzene
C14H11BrClNO2
Acta Crystallographica Section E (2010) 66, 12 o3358
a=15.7756(4)Å b=7.3795(2)Å c=11.5236(3)Å
α=90.00° β=90.00° γ=90.00°
Levocetirizinium dipicrate
C21H27ClN2O32,2(C6H2N3O7)
Acta Crystallographica Section E (2010) 66, 12 o3167
a=11.24440(10)Å b=15.7720(2)Å c=20.6204(2)Å
α=90.00° β=95.9980(10)° γ=90.00°
Methyl 2,2-diphenyl-2-(prop-2-yn-1-yloxy)acetate
C18H16O3
Acta Crystallographica Section E (2012) 68, 3 o874
a=12.6771(17)Å b=9.2410(13)Å c=12.7055(18)Å
α=90.00° β=93.090(3)° γ=90.00°
2-(2-Benzylphenyl)propan-2-ol
C16H18O
Acta Crystallographica Section E (2011) 67, 12 o3302
a=12.2252(3)Å b=17.2508(4)Å c=16.7784(3)Å
α=90.00° β=132.5490(10)° γ=90.00°
3,3-Dimethyl-2-benzofuran-1(3<i>H</i>)-one
C10H10O2
Acta Crystallographica Section E (2012) 68, 1 o113
a=14.3537(9)Å b=7.0069(5)Å c=8.2605(5)Å
α=90° β=90° γ=90°
2-Amino-<i>N</i>-[3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl]acetamide
C15H15ClN2O2S
Acta Crystallographica Section E (2012) 68, 2 o547-o548
a=13.9784(11)Å b=13.5565(11)Å c=8.3334(7)Å
α=90.00° β=91.2330(10)° γ=90.00°
Loperamide monohydrate
C29H33ClN2O2,H2O
Acta Crystallographica Section E (2012) 68, 2 o539-o540
a=16.7869(4)Å b=15.1506(6)Å c=20.6617(6)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-5-(2-Chlorophenyl)-7-ethyl-2-oxo-2,3-dihydro-1<i>H</i>-thieno[2,3-<i>e</i>][1,4]diazepin-4-ium 2,4,6-trinitrophenolate
C15H14ClN2OS,C6H2N3O7
Acta Crystallographica Section E (2012) 68, 2 o516-o517
a=10.5704(2)Å b=20.0667(5)Å c=11.3741(2)Å
α=90.00° β=110.6660(10)° γ=90.00°
1-[Bis(4-fluorophenyl)methyl]piperazine
C17H18F2N2
Acta Crystallographica Section E (2012) 68, 9 o2817
a=12.1574(5)Å b=8.8559(2)Å c=13.8604(4)Å
α=90.00° β=93.355(3)° γ=90.00°
Flunarizinium hydrogen maleate
C26H27F2N2,C4H3O4
Acta Crystallographica Section E (2013) 69, 8 o1344
a=22.1215(5)Å b=10.8620(2)Å c=11.3215(2)Å
α=90° β=98.879(2)° γ=90°